Rapid control of a massive hemorrhage is vitally important to patient survival. Fibrinogen rapidly depletes in bleeding patients and is an independent indicator for severe hemorrhage. Early fibrinogen replacement in bleeding patients may improve patient outcomes. This course will review key clinical trials and the treatment options available for the replacement of fibrinogen in bleeding patients.
- Learn about the advancement of hemorrhage control and the MTP
- Discuss the importance of fibrinogen and what makes a healthy clot
- Assess early replacement of fibrinogen in bleeding patients
- Differentiate Cryoprecipitate AHF, Fibrinogen Concentrates, and Pathogen Reduced Cryoprecipitate Fibrinogen Complex
- Analyze studies focusing on cryoprecipitate use and fibrinogen replacement
Level of Instruction
Author / Speaker
Jeffrey Richmond, M.D.
Director of Hospital Transfusion Services
AHN / St. Vincent Hospital, Erie, PA
Jeff Richmond is a general pathologist with subspecialty board certification in blood banking/transfusion medicine. Jeff has been a staff pathologist at AHN-Saint Vincent Hospital in Erie, PA for 14 years, where he practices anatomic and clinical pathology and serves as director of the hospital transfusion service. In addition, Jeff is the medical director of the Community Blood Bank of Northwest Pennsylvania and Western New York, and medical director of Associated Clinical Laboratories, both in Erie. Jeff earned his MD degree from West Virginia University, followed by AP/CP pathology residency at University of Vermont, and fellowship training at University of Pittsburgh Medical Center.
Cerus Corporation is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
Contact Hour: 1.0
Expires on: Jun 25, 2024 at 11:59 pm CT
This program is approved by the California Board of Registered Nursing, Provider Number CEP15148 for 1.0 contact hours
Contact Hour: 1.0
Expires at: Jun 25, 2023 at 12:00 am CT
Technical Requirements and Assistance
Questions or Comments
Please contact firstname.lastname@example.org.